Insulet Corp
PODD: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|$@ | LOCK|cG#y& | LOCK|&<P>@j^ |
Insulet Earnings: Stellar Growth Comes at Expense of Key Competitor
Insulet posted second-quarter revenue of $649 million, an increase of 31% in constant currency, with strong growth from both the US and international markets. Adjusted operating margin rose 670 basis points, driven primarily by lower sales and marketing expense.
